GlobeNewswire 2021-10-05 Certara Appoints Drayton T. Virkler as Chief Commercial Officer
GlobeNewswire 2021-09-30 GigaGen Licenses ProteoNic’s 2G UNicTM Technology Platform for High Yield Production of GigaGen’s Mo...
GlobeNewswire 2021-08-11 GigaGen Doses First Patient in Phase 1 Trial of Recombinant Hyperimmune Polyclonal Antibody GIGA-205...
GlobeNewswire 2021-07-28 Alkahest Strengthens Management Team with Addition of César Cerezo as Chief Medical Officer
GlobeNewswire 2021-07-14 GigaGen Publishes Research Describing Novel Mechanism of Action and Therapeutic Potential of its ant...
GlobeNewswire 2021-05-25 GigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to anti-PD-L1 The...
GlobeNewswire 2021-05-14 Ferroglobe Announces New Appointments and Changes to the Board of Directors
GlobeNewswire 2021-04-15 GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
GlobeNewswire 2021-04-02 Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating ...
GlobeNewswire 2021-03-23 GigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual...
GlobeNewswire 2021-03-08 Alkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Co...
GlobeNewswire 2020-09-15 Stifel Bolsters Healthcare Services Investment Banking Team With Three New Managing Directors
TeleTrader 2020-07-28 Grifols says its anti-COVID-19 therapeutics ready for trials
GlobeNewswire 2020-07-09 Alkahest Provides Corporate Update
GlobeNewswire 2020-06-01 Alkahest Announces Initiation of Phase 2 Study AKST1210-201 Exploring Treatment of Cognitive Impairm...
GlobeNewswire 2020-05-28 Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activi...
GlobeNewswire 2020-04-24 Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
GlobeNewswire 2020-03-30 GigaGen Initiates Development of Recombinant Polyclonal Antibody Therapy for COVID-19
GlobeNewswire 2020-02-10 Alkahest Announces Initiation of Phase 2b Clinical Trial of AKST4290 in Patients with Treatment-Naïv...
GlobeNewswire 2020-02-04 Alkahest Initiates a Phase 2 Clinical Trial of AKST4290 in Parkinson’s Disease with Funding from The...
GlobeNewswire 2020-01-15 BioCryst Strengthens Commercial Rare Disease Leadership
GlobeNewswire 2019-12-17 Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of AKST4290 on Choroidal Blood Flow in Age...
GlobeNewswire 2019-12-12 Nufactor® Selected by Grifols to be Included in the Limited Network of Specialty Pharmacies for XEMB...
GlobeNewswire 2019-12-09 Alkahest Presents Data from Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease
GlobeNewswire 2019-12-02 Alkahest to Present New Data from Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease at the Clin...